Cargando…
Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
Research on cancer epigenetics has flourished in the last decade. Nevertheless growing evidence point on the importance to understand the mechanisms by which epigenetic changes regulate the genesis and progression of cancer growth. Several epigenetic targets have been discovered and are currently un...
Autores principales: | Andreol, Federico, Barbosa, Arménio Jorge Moura, Daniele Parenti, Marco, Rio, Alberto Del |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529403/ https://www.ncbi.nlm.nih.gov/pubmed/23016851 http://dx.doi.org/10.2174/138161213804581918 |
Ejemplares similares
-
Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective
por: Finnerty, Brendan M, et al.
Publicado: (2017) -
Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023) -
Inhibition of Human Dyskerin as a New Approach to Target Ribosome Biogenesis
por: Rocchi, Laura, et al.
Publicado: (2014) -
Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression
por: Ratovitski, Edward A.
Publicado: (2017) -
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
por: Ghanem, Moustafa S., et al.
Publicado: (2022)